CannaFundraise.com is a crowdfunding platform which provides accredited investors with a portal to evaluate and invest into exceptional medical cannabis ancillary companies that are positioned for growth to achieve healthy returns. As an online investment website with built-in equity crowdfunding engine, CannaFundraise offers angel investors and venture capitals a venue to vet out deals and invest in exceptional companies in the fast-growing cannabis market. We provide accredited investors with opportunities to evaluate and invest in early stage ancillary companies in the medical marijuana industry under SEC Reg A+, 506d and 506c.
The growth of the marijuana industry is increasing year-over-year and being accepted by more Americans. With 29 states and District of Columbia (DC) currently have laws legalizing medical marijuana use and 8 states have laws legalizing recreational marijuana use, the growing marijuana industry is making billions of dollars in sales and providing millions in recurring taxes. The new federal regulation under the Job’s act is now making it easier for accredited investors to buy into this growing market which is expected to reach over $25 billion market by 2020.
Listed ancillary medical cannabis companies on CannaFundraise.com creates a new channel for accredited investors interested in investing in the legal marijuana industry. CannaFundraise.com makes investing easier for accredited investors seeking to invest in cannabis companies by preselecting and vetting out exceptional companies with bright future. CannaFundraise provides capital and connections to listed portfolio companies to help propel growth. Recently, two selected companies listed are HempTech Corp and Biotica Pharmaceuticals;
HempTech Corp, www.hemptechcorp.com, is a technology company providing specialized solutions for cultivating cannabis. We design and engineer intelligent, efficient, industrial-grade solutions with automated process control, premium environmental sensors, data analytics, visualization software and security solutions. Our goal is to provide licensed growers the ability to compete in the emerging markets by producing high quality medical-grade cannabis.
Biotica Pharmaceuticals, www.bioticapharma.com, led by big pharma veterans, is an early-stage biotech founded by a group of pioneers in the cannabis technology landscape. Biotica Pharmaceuticals, a biopharmaceutical company, together with its subsidiaries, will engage in discovering, developing, and commercializing cannabinoid-based medicines. It will operate through three segments: 1) Commercial, 2) Drug delivery systems and methods, 3) Cannabinoids Research and Development for Neuropathic pain, Cancer, Alzheimer’s, Parkinson, Esophagitis, and Immune Enhancement.
The Company is expected to list more exciting companies on CannaFundraise.com in the coming months. For more information please contact – firstname.lastname@example.org.
About FutureWorld Corp.
FutureWorld (FWDG), a Delaware corporation, is a leading provider of advanced technologies and solutions to the global cannabis industry. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products and services, such as industrial Hemp. FutureWorld, through its subsidiaries, provides personal and professional THC and CBD test kits, pharmaceutical grade CBD oil solutions, SafeVape vaporizers, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana.
As the only Cannabis Technology Accelerator, FutureWorld will incubate and fund leading technologies, products, and services for Cannabis industry (Industrial Hemp) for foreseeable future; bringing value to its core and its shareholders. To request further information about FutureWorld, please email us at email@example.com, log onto our website at http://www.futureworldcorp.com or visit us at our Facebook page facebook.com/futureworldcorp or on Twitter @futureworldinc.
This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words “plan,” “expect,” “believe,” and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.